{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:05:29Z","timestamp":1791198329172,"version":"4.1.0"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To explore the clinical characteristics of recurrent pediatric anti-glutamic acid decarboxylase 65 (GAD65) antibody-associated autoimmune encephalitis and to enhance understanding of this disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective analysis of the clinical data of a pediatric patient with recurrent anti-GAD65 antibody-associated encephalitis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The patient was a 7-year-old boy who presented with slurred speech and epileptic seizures in June 2024. Brain magnetic resonance imaging(MRI)demonstrated multiple abnormal signal intensities in the bilateral frontal, temporal, parietal, and occipital cortical regions. Electroencephalogram (EEG) revealed focal epileptiform discharges and status epilepticus. His clinical condition improved following treatment with methylprednisolone and intravenous immunoglobulin. In November 2024, the child presented with a decline in mental status, generalized weakness, increased somnolence, reduced mobility and social interaction, gait instability, as well as accompanying headache and vomiting. Brain MRI demonstrated inflammatory involvement of the right cerebellar hemisphere. The cerebrospinal fluid (CSF) analysis revealed a white blood cell count of 17\u00d710\n                      <jats:sup>6<\/jats:sup>\n                      \/L. Anti- GAD antibody IgG was positive in both serum and cerebrospinal fluid, with a titer of 1:100.The diagnosis of anti-GAD65 antibody-associated encephalitis was well-established. The clinical symptoms of the child showed improvement following the administration of methylprednisolone and immunoglobulin therapy. Following discharge, monthly administration of immunoglobulin therapy was initiated. In February 2025, the child presented with tremors in the right foot, a repeat MRI scan of the cranial revealed an increase in multiple abnormal signals within the brain compared to prior imaging studies, indicating the presence of new lesions. Concurrently, testing for anti-GAD65 antibodies was positive, with titers of 1:1 in CSF and 1:32 in serum. These findings were interpreted as indicative of a relapse of anti-GAD65 antibody-associated encephalitis. Following the administration of a repeat methylprednisolone pulse therapy, the child\u2019s symptoms showed improvement, and sequential treatment with rituximab was subsequently initiated. During the follow-up visit in September 2025, the pediatric patient remained asymptomatic with no evidence of disease recurrence.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We present a detailed case report of recurrent anti-GAD65 antibody-associated encephalitis in a pediatric patient, characterized by complex and variable clinical manifestations. Rituximab demonstrated therapeutic effectiveness in managing this recurrent condition.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1729994","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T05:36:11Z","timestamp":1768973771000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Case Report: Recurrent anti-glutamic acid decarboxylase 65 antibody-associated encephalitis in a child"],"prefix":"10.3389","volume":"17","author":[{"given":"Pingping","family":"Tian","sequence":"first","affiliation":[{"name":"Neurology department, Children\u2019s Hospital Affiliated to Shandong University","place":["Jinan, Shandong, China"]},{"name":"Neurology department, Jinan Children\u2019s Hospital","place":["Jinan, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Li","sequence":"additional","affiliation":[{"name":"Neurology department, Children\u2019s Hospital Affiliated to Shandong University","place":["Jinan, Shandong, China"]},{"name":"Neurology department, Jinan Children\u2019s Hospital","place":["Jinan, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Liu","sequence":"additional","affiliation":[{"name":"Neurology department, Children\u2019s Hospital Affiliated to Shandong University","place":["Jinan, Shandong, China"]},{"name":"Neurology department, Jinan Children\u2019s Hospital","place":["Jinan, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiufang","family":"Ding","sequence":"additional","affiliation":[{"name":"Neurology department, Children\u2019s Hospital Affiliated to Shandong University","place":["Jinan, Shandong, China"]},{"name":"Neurology department, Jinan Children\u2019s Hospital","place":["Jinan, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Neurology department, Children\u2019s Hospital Affiliated to Shandong University","place":["Jinan, Shandong, China"]},{"name":"Neurology department, Jinan Children\u2019s Hospital","place":["Jinan, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn113694-20220219-00118","article-title":"Chinese expert consensus on the diagnosis and management of autoimmune encephalitis (2022 edition)","volume":"55","year":"2022","journal-title":"Chin J Neurol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/ana.21050","article-title":"Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma","volume":"61","author":"Dalmau","year":"2007","journal-title":"Ann Neurol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02708","article-title":"Management of autoimmune encephalitis: an observational monocentric study of 38 patients","volume":"9","author":"Macher","year":"2018","journal-title":"Front Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21103701","article-title":"Neurological syndromes associated with anti-GAD antibodies","volume":"21","author":"Dade","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-020-0359-x","article-title":"GAD antibodies in neurological disorders - insights and challenges","volume":"16","author":"Graus","year":"2020","journal-title":"Nat Rev Neurol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1177\/17562864211003486","article-title":"GAD antibody-spectrum disorders: progress in clinical phenotypes, immunopathogenesis and therapeutic interventions","volume":"14","author":"Tsiortou","year":"2021","journal-title":"Ther Adv Neurol Disord"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2020-325275","article-title":"Clinical spectrum of high-titre GAD65 antibodies","volume":"92","author":"Budhram","year":"2021","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B8","volume-title":"Clinical Analysis of 6 Cases of Anti-glutamic Acid Decarboxylase65 Antibody Encephalitis and Literature Review","author":"Gu","year":"2025"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198804213181602","article-title":"Autoantibodies to glutamic acid decarboxylase in a patient with stiff-man syndrome, epilepsy, and type I diabetes mellitus","volume":"318","author":"Solimena","year":"1988","journal-title":"N Engl J Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"E50","DOI":"10.1542\/peds.109.3.e50","article-title":"Type 1 diabetes mellitus and epilepsia partialis continua in a 6-year-old boy with elevated anti-GAD65 antibodies","volume":"109","author":"Olson","year":"2002","journal-title":"Pediatrics"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2015.00167","article-title":"Treating a GAD65 antibody-associated limbic encephalitis with basiliximab: A case study","volume":"6","author":"Widman","year":"2015","journal-title":"Front Neurol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpn.2018.01.004","article-title":"Severe dysautonomia as a main feature of anti-GAD encephalitis: Report of a paediatric case and literature review","volume":"22","author":"Ben Achour","year":"2018","journal-title":"Eur J Paediatr Neurol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fnbeh.2015.00078","article-title":"Disease-specific monoclonal antibodies targeting glutamate decarboxylase impair GABAergic neurotransmission and affect motor learning and behavioral functions","volume":"9","author":"Manto","year":"2015","journal-title":"Front Behav Neurosci"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-022-01188-w","article-title":"Stiff-person syndrome and GAD antibody-spectrum disorders: GABAergic neuronal excitability, immunopathogenesis and update on antibody therapies","volume":"19","author":"Dalakas","year":"2022","journal-title":"Neurotherapeutics"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000696","article-title":"Neurologic syndromes related to anti-GAD65: Clinical and serologic response to treatment","volume":"7","author":"Mu\u00f1oz-Lopetegi","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25414","article-title":"Abundant glutamic acid decarboxylase (GAD)-reactive B cells in gad-antibody-associated neurological disorders","volume":"85","author":"Thaler","year":"2019","journal-title":"Ann Neurol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.641024","article-title":"Case report: autoimmune encephalitis associated with anti-glutamic acid decarboxylase antibodies: A pediatric case series","volume":"12","author":"Ren","year":"2021","journal-title":"Front Neurol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2022.1081580","article-title":"The clinical relevance of anti-glutamic acid decarboxylase antibodies in children with encephalitis\/encephalopathy","volume":"16","author":"Hou","year":"2022","journal-title":"Front Neurosci"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1097\/MS9.0000000000001653","article-title":"Successfully treated anti-GAD limbic encephalitis in a 15-year-old diabetic boy with intravenous immunoglobulin: case report","volume":"86","author":"Fattahzadeh Ardalani","year":"2024","journal-title":"Ann Med Surg (Lond)"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1274672","article-title":"A case report of anti-GAD65 antibody-positive autoimmune encephalitis in children associated with autoimmune polyendocrine syndrome type-II and literature review","volume":"14","author":"Sapana","year":"2023","journal-title":"Front Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2012.06.013","article-title":"Antiglutamic acid decarboxylase antibodies in children with encephalitis and status epilepticus","volume":"47","author":"Lin","year":"2012","journal-title":"Pediatr Neurol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2014.1011","article-title":"Cerebellar ataxia and glutamic acid decarboxylase antibodies: immunologic profile and long-term effect of immunotherapy","volume":"71","author":"Ari\u00f1o","year":"2014","journal-title":"JAMA Neurol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2022.120540","article-title":"Glutamic acid decarboxylase antibody-associated neurological syndromes: Clinical and antibody characteristics and therapy response","volume":"445","author":"Madlener","year":"2023","journal-title":"J Neurol Sci"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1111\/cns.70237","article-title":"Clinical features of glutamic acid decarboxylase-65 neurological autoimmunity: A case series from China","volume":"31","author":"Qiu","year":"2025","journal-title":"CNS Neurosci Ther"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000001088","article-title":"Rituximab treatment and long-term outcome of patients with autoimmune encephalitis: real-world evidence from the GENERATE registry","volume":"8","author":"Thaler","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2018.06.013","article-title":"Fulminant Anti-GAD antibody encephalitis presenting with status epilepticus requiring aggressive immunosuppression","volume":"323","author":"Triplett","year":"2018","journal-title":"J Neuroimmunol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1136\/jnnp-2020-325302","article-title":"Autoimmune Encephalitis Alliance Clinicians Network. Autoimmune encephalitis: proposed recommendations for symptomatic and long-term management","volume":"92","author":"Abboud","year":"2021","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1729994\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T07:39:44Z","timestamp":1771918784000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1729994\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,21]]},"references-count":27,"alternative-id":["10.3389\/fimmu.2026.1729994"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1729994","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,21]]},"article-number":"1729994"}}